Stifel Nicolaus Begins Coverage on Crescent Biopharma (NASDAQ:CBIO)
Equities research analysts at Stifel Nicolaus assumed coverage on shares of Crescent Biopharma (NASDAQ:CBIO – Get Free Report) in a report released on Wednesday, MarketBeat Ratings reports. The brokerage set a “buy” rating and a $28.00 price target on the biopharmaceutical company’s stock. Stifel Nicolaus’ price target points to a potential upside of 65.68% from […]
Equities research analysts at Stifel Nicolaus assumed coverage on shares of Crescent Biopharma (NASDAQ:CBIO – Get Free Report) in a report released on Wednesday, MarketBeat Ratings reports. The brokerage set a “buy” rating and a $28.00 price target on the biopharmaceutical company’s stock. Stifel Nicolaus’ price target points to a potential upside of 65.68% from […]
